Recent advances of studies on the therapy-related myelodysplastic syndromes/acute myeloid leukemia / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 1757-1760, 2014.
Artículo
en Chino
| WPRIM
| ID: wpr-259657
ABSTRACT
Therapy-related myelodysplasia syndromes/acute myeloid leukemia (t-MDS/AML) is a clinical syndrome occurring as a late complication after chemotherapy and (or) radiotherapy, attracting much more attention owing to the improved treatment agents and longer survival of many treated patients. According to the WHO classification of 2008, t-MDS/AML is a serious complication of chemotherapy or radiotherapy given to a malignant or nonmalignant condition consisting of t-AML, t-MDS and t-MDS/myeloproliferative diseases (t-MDS/MPD). This review mainly focuses on the pathogenesis, relationship with primary tumour, treatment and prognosis of t-MDS/AML.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pronóstico
/
Terapéutica
/
Síndromes Mielodisplásicos
/
Leucemia Mieloide Aguda
/
Neoplasias Primarias Secundarias
/
Trastornos Mieloproliferativos
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Experimental Hematology
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS